• Intellia Therapeutics President and CEO John M. Leonard sold 9,000 shares of common stock at $11.99 on Nov. 2, 2026.
• Following the sale, Leonard held 1,138,064 shares directly, with another 58,415 shares held indirectly through a trust.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-445417), on November 03, 2026, and is solely responsible for the information contained therein.